- Report
- March 2025
China
From €1999EUR$2,095USD£1,675GBP
€3808EUR$3,990USD£3,191GBP
- Report
- March 2025
Global
From €1999EUR$2,095USD£1,675GBP
€3808EUR$3,990USD£3,191GBP
- Book
- July 2018
- 106 Pages
- Report
- March 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- March 2025
- 65 Pages
Europe
From €1813EUR$1,900USD£1,519GBP
- Report
- November 2021
- 270 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- November 2021
- 365 Pages
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- October 2024
- 280 Pages
Global
From €2534EUR$2,655USD£2,123GBP
- Report
- July 2022
- 275 Pages
Global
From €3407EUR$3,570USD£2,855GBP
- Book
- December 2022
- 560 Pages
- Book
- August 2023
- 464 Pages
- Book
- September 2008
- 320 Pages
- Book
- March 2024
- 544 Pages

Nucleic acids are molecules that are essential for life and are found in all living organisms. They are the building blocks of DNA and RNA, and are used in biotechnology for a variety of applications, such as gene therapy, diagnostics, and drug discovery. Nucleic acid-based technologies are used to identify, analyze, and manipulate genetic material.
The nucleic acids market is a rapidly growing segment of the biotechnology industry. It is driven by advances in sequencing technology, which has enabled the development of new applications and products. The market is also driven by the increasing demand for personalized medicine, which requires the use of nucleic acid-based technologies.
Companies in the nucleic acids market include Thermo Fisher Scientific, Illumina, Agilent Technologies, Qiagen, and Bio-Rad Laboratories. Show Less Read more